Profile
Peter A. LaCrosse is currently the President & Chief Operating Officer at Precidiag, Inc. He previously worked as the Vice President-US Operations at febit holding GmbH and as the Chief of Staff at Arch Therapeutics, Inc. LaCrosse completed his undergraduate degree at Embry-Riddle Aeronautical University.
Peter A. LaCrosse active positions
| Companies | Position | Start |
|---|---|---|
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | President | - |
Former positions of Peter A. LaCrosse
| Companies | Position | End |
|---|---|---|
| ARCH THERAPEUTICS, INC. | Human Resources Officer | - |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services Designs and develops technologies for DNA analysis | Corporate Officer/Principal | - |
Training of Peter A. LaCrosse
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Embry-Riddle Aeronautical University
Embry-Riddle Aeronautical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services Designs and develops technologies for DNA analysis | Health Services |
Arch Therapeutics, Inc.
Arch Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel approach to stop bleeding, control leaking and manage wounds during surgery, trauma & interventional care | Health Technology |
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | Technology Services |
- Stock Market
- Insiders
- Peter A. LaCrosse
















